← All trials
NCT03832660
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 22, 2019
- Primary completion
- May 31, 2021
- Completion date
- Nov 30, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 225
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Newcastle UniversityLead sponsor
- University of RegensburgCollaborator
- University of FlorenceCollaborator
- Assistance Publique - Hôpitaux de ParisCollaborator
- Newcastle UniversityReponsible party - principal investigator
- Newcastle UniversityOverall official - principal investigator
- Institute for Cardiovascular Diseases of VojvodinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.